drugset / Trial / NCT01114204

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

NCT01114204

Phase 3 Completed 605 enrolled AMAG Pharmaceuticals, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA).

Timeline

Start
2010-08-10
Primary completion
2011-11-09
Completion
2012-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferumoxytol Diagnostic / imaging agent 510 mg Intravenous
Comparator Iron sucrose Unknown 200 mg Intravenous